LexisNexis® Legal Newsroom
Plaintiffs' Lawyers Pursue Non-U.S. Securities Litigation Alternatives After Morrison

One of the questions posed in the wake of the U.S. Supreme Court's landmark decision in Morrison v. National Australia Bank is whether the Court's holding might encourage securities claimants foreclosed by Morrison from U.S. court to attempt to pursue their claims in their home countries or in...

New Trends In Securities Litigation Emerged In 2010, According To PwC Study

A number of trends that had predominated in recent years diminished during 2010 while new trends emerged, according to PwC's 2010 Securities Litigation Study, which can be found here . 2010 may also mark "the start of a new era" as a consequences of a new regulatory and enforcement environment...

2 New Credit Crisis-Related Securities Lawsuits Raise Interesting Issues

As the worst days of the financial crisis (if not their ill effects) receded into the past, the accompanying credit crisis-related litigation wave appeared to lose its momentum. By late 2010, new credit crisis-related lawsuit filings seemingly had dwindled away. But now at the midpoint of 2011, two new...

Will Supreme Court's Wal-Mart Ruling Affect Securities Class Action?

In the wake of the U.S. Supreme Court's landmark June 20, 2011 decision in Wal-Mart Stores v. Dukes , numerous commentators have asserted that the case could have a significant impact on future class actions. For example, one law firm's memo about the case stated that the decision "should...

Academics Identify Factors That Affect Outcomes Of Securities Class Action Lawsuits

A great deal of the analysis of securities class action lawsuit settlements revolves around measures of aggregate, average and median settlement amounts. These data, while useful, are relatively unhelpful in trying to anticipate the outcome of any particular case, particularly at the outset. To try to...

Securities Class Action Lawsuits Against Life Sciences Companies Rose In 2012

The number of securities class action lawsuits filed against life sciences companies rose in both absolute and relative terms in 2012, according to a March 20, 2013 memorandum by David Kotler of the Dechert law form entitled "Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences...